A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Carsten Flohr, Abaigeal Jackson et al.|Skin Health and Disease|2025Cited by 1
P122 Conducting federated treatment effectiveness analyses for systemic therapies in atopic dermatitis across country borders: methodological considerations from the DREAM TO TREAT AD projectElizaveta Gribaleva, Carsten Flohr, David Prieto‐Merino et al.|British Journal of Dermatology|2025Cited by 0